Vitiligo is a common condition causing loss of pigmentation in patches of skin. Although vitiligo may be more noticeable in darker skin, it can have a considerable effect on psychological wellbeing in anyone who is affected by the condition.
Many previous clinical trials of treatments for vitiligo have been small or poorly designed. There has also been wide variation in the outcome measures used to measure the effects of vitiligo treatments. We have addressed these issues by:
HI-LIGHT Vitiligo Trial - Examining whether UV-light (used at home) and topical steroids help vitiligo.
Maxine Whitton MBE, shares her experience of taking part in one of our vitiligo trials.
Vitiligo Prioritisation Partnership - Training on how to use hand-held narrowband ultraviolet light (NB-UVB) devices safely
Vitiligo Noticeability scale - A patient-rated outcome measure assessing the acceptability of treatment response.
Vitiligo Noticeability scaleA patient-rated outcome measure assessing the acceptability of treatment response.
Core Outcomes for VitiligoDeveloping a Core Outcome Set for vitiligo - International Initiative for outcomes for vitiligo trials (INFO)
Using hand-held light devices for vitiligoTraining on how to use hand-held narrowband ultraviolet light (NB-UVB) devices safely.
How to perform a MED testA training resource to demonstrate how to perform an Minimal Erythema Dose (MED) test.
Maps of systematic reviews Maps of systematic reviews on vitiligo by topic
Handbook for using NB-UVB Light Devices and topical corticosteroids A guide for local medical teams developing protocols for home treatment of vitiligo.
The University of Nottingham
Applied Health Research Building
University Park, Nottingham
telephone: +44 (0) 115 84 68631
Connect with the University of Nottingham through social media and our blogs.
Campus maps | More contact information | Jobs